Related Experiment Video
Updated: Mar 2, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
Erectile dysfunction - overview from a cardiovascular perspective
Frederic Baumann1, Deborah Hehli2, Vladimir Makaloski3
11 Clinical and Interventional Angiology, UniversitätsSpital Zürich, Zurich, Switzerland.
Erectile dysfunction (ED) affects aging men and is linked to cardiovascular disease. Endovascular therapy offers minimally invasive treatment for arteriogenic ED caused by atherosclerosis, but requires more research.
Area of Science:
- Urology
- Cardiology
- Vascular Medicine
Background:
- Erectile dysfunction (ED) is increasingly prevalent in aging males.
- ED shares cardiovascular risk factors and can predict chronic diseases.
- Common causes include neurogenic, psychogenic, arteriogenic, and venogenic factors, with atherosclerosis often underlying arteriogenic ED.
Purpose of the Study:
- To review the role of endovascular therapy in managing erectile dysfunction.
- To highlight the connection between ED and cardiovascular health.
- To discuss current diagnostic and therapeutic approaches for ED.
Main Methods:
- Literature review focusing on endovascular techniques for ED.
- Analysis of the relationship between ED etiology and cardiovascular risk factors.
- Discussion of patient referral pathways for vascular diagnostics and therapy.
Main Results:
- Arteriogenic ED is frequently linked to atherosclerosis.
- Endovascular therapy enables minimally invasive revascularization of relevant arteries.
- Conservative treatments may be insufficient for some patients.
Conclusions:
- Endovascular therapy presents a minimally invasive option for specific cases of ED.
- Further scientific investigation is needed to clarify the role of endovascular therapy in multifactorial ED.
- ED management requires a comprehensive approach considering cardiovascular health.
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Cardiovascular Drugs: Classification based on Therapeutic Indications
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Male Sexual Response: Erection & Ejaculation
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...

